Navigation Links
ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries
Date:11/21/2009

WASHINGTON, Nov. 21 /PRNewswire/ -- An urgent need for new medicines to treat neglected infectious diseases in the developing world has prompted a growing number of collaborations among academic researchers, non-profit product development partnerships (PDPs), and pharmaceutical and biotechnology companies. As noted today in a symposium at the 58th annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH), these collaborations are opening up new avenues of access to industry technology, expertise, and capabilities, enabling the harnessing of industry resources for new product innovation.

The need for these collaborations between industry and global health non-profits results from the lack of effective prevention or treatments for many infectious diseases of the developing world. There is a tremendous need for new R&D that could lead to new cures. Despite substantial progress in improving delivery of existing medicines for infectious diseases in the developing world, there are still major gaps in disease prevention, diagnosis, and treatment that must be alleviated through development of new medicines.

"Industry/public sector product development collaborations are one of the success stories for the developing world, as biopharmaceutical companies are discovering that investment in global health R&D is consistent with their broader commercial strategies," observed Dr. Christopher D. Earl, former chief executive officer of BIO Ventures for Global Health, who organized the symposium. "The participants in this symposium highlight how their organizations have made substantial progress in moving unused compounds from companies' shelves to the laboratory and ultimately to the clinic. By allowing experts access to assets that industry has amassed, these collaborations have spurred the development of new medicines for malaria, tuberculosis, and various parasite-borne diseases."

The symposium, "Rummag
'/>"/>

SOURCE The American Society of Tropical Medicine and Hygiene
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17, 2009
2. US Oncology, Inc. to Exhibit iKnowMed(TM) at the 2009 ASCO EHR Symposium: Harnessing the EHR: From Incentives to Sustainability
3. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
4. DaVita Abstracts Accepted Into National Kidney Foundations 2009 Spring Symposium
5. Anti-Aging Expo & Symposium Showcases in Charlotte on March 28th
6. Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections
7. Hope for 14 Million Rosacea Sufferers: Pyratine-XR(TM) Study to be Presented at South Beach Symposium
8. Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium
9. Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium
10. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
11. Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... 2013 Velplex, LLC announced this week that ... that connects buyers and sellers of discount dental ... Why? It,s because the business leaders ... with the dental industry. They have 50 years of ... worked to negotiate some of the best prices in ...
(Date:6/17/2013)... , June 17, 2013 Vanda ... presented additional data today at ENDO 2013, the ... that tasimelteon can entrain (synchronize) both melatonin and ... to reset the master body clock and address ... Disorder (Non-24).  The SET (Safety and Efficacy of ...
(Date:6/17/2013)...  Hanger, Inc. (NYSE:  HGR) today announced the signing ... senior secured facilities to an aggregate of up to ... agreement includes a $200 million revolving credit facility and ... agreement was comprised of a $100 million revolving credit ... facility matures on June 17, 2018, and is subject ...
Breaking Medicine Technology:TopProdeals.com Rises to Top as Discount Dental Supply Leader 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 2Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 3
... 2011 Watson Pharmaceuticals, Inc. (NYSE: ... has received U.S. Food and Drug Administration ("FDA") ... for Enoxaparin Sodium Injection in the 100mg/mL and ... equivalent to Sanofi-aventis, LOVENOX®, and is a low ...
... SYDNEY, Sept. 19, 2011 HeartWare International, Inc. (NASDAQ: ... innovator of less invasive, miniaturized circulatory support technologies that ... announced that CEO Doug Godshall is scheduled to present ... Device Day at 1:55 p.m. ET on Thursday, September ...
Cached Medicine Technology:Watson Pharmaceuticals Announces Approval of Amphastar's Generic LOVENOX(R) 2Watson Pharmaceuticals Announces Approval of Amphastar's Generic LOVENOX(R) 3HeartWare to Present at The Lazard Capital Markets 3rd Annual Circulatory Assist Device Day 2
(Date:6/17/2013)... 17, 2013 Daily Gossip Magazine has ... a thorough review of the Tinnitus Miracle treatment ... presents the natural treatment that Coleman suggests ... have tested it. , Based on the information provided ... Tinnitus treatment suggested by Thomas Coleman is different ...
(Date:6/17/2013)... New York, New York (PRWEB) June 17, 2013 ... associated with products manufactured by C.R. Bard, Inc. ... underway in New Jersey’s Atlantic County Superior Court, Bernstein ... a new Consent Order that set forth protocols for ... samples for the litigation’s bellwether cases. Court documents ...
(Date:6/17/2013)... June 17, 2013 The producers of ... new series of reports highlighting how sustainable farming techniques ... growing populations and their demand on food supplies. , ... produced television series airing in markets around the country ... legendary Martin Sheen, who is marking the start of ...
(Date:6/17/2013)... 2013 Ayurveda Chile is the ... or wisdom of life." As a mind-body-spirit medicine, its scope ... of consciousness. Its fundamental philosophy is that disease is the ... In order to re-establish optimal health, one must discover where ... life style which brings us back into perfect harmony and ...
(Date:6/17/2013)... York, NY (PRWEB) June 17, 2013 The ... Yohan Blake to attend the Festival this summer, which will ... 18th through Sunday, August 25th. , Blake professes the ... bananas a day to fuel his world class sprinting ... large volume of fruit is drawing attention. "Yohan Blake believes ...
Breaking Medicine News(10 mins):Health News:Thomas Coleman's Tinnitus Miracle Treatment Review Discloses Alternative Natural Cure 2Health News:Transvaginal Mesh Lawyers at Bernstein Liebhard LLP Note New Order in New Jersey C.R. Bard Litigation Concerning Handling of Explants and Tissue Samples 2Health News:Transvaginal Mesh Lawyers at Bernstein Liebhard LLP Note New Order in New Jersey C.R. Bard Litigation Concerning Handling of Explants and Tissue Samples 3Health News:Ayurveda Chile Program Offered by Escuela Ayurveda de California in August, 2013 2Health News:Yohan Blake Invited to The Woodstock Fruit Festival as Guest of Honor 2
... reports the latest research done in Britain claim that ... //cancer successfully after having studied over 2,400 patients. The ... effectiveness of adding the drug epirubicin to regular chemotherapy ... cancer. Both studies reported better results of treatment ...
... government officials continue to extol the virtues of the NHS, ... to protest against the policies of the NHS. // ... and increased staff numbers but NHS staff including doctors, nurses, ... of Westminster to protest aginst disastrous policies. ,Pensioners ...
... that has worked against different strains of Staphylococcus aureus ... promising step towards designing a vaccine which can be used ... study was done by researchers at the University of Chicago ... Infectious Diseases. , Dr. Olaf Schneewind and colleagues at ...
... at the Harvard Medical School and the National Institute on ... found in red wine, and the skin of red ... with calories and may significantly affect the longevity ... journal Nature, explains that a daily intake of ...
... medical consultations and patients are seen tapping the online ... ailments, especially ones they would like to hide in ... scored very high on the search list and back ... of attention.NHS direct, the helpline is known to answer ...
... less inclined to commit suicide as compared to Whites was ... among black Americans. Scientists from the University of Michigan said ... ones own life happens to be the 11th leading cause ... that nearly one in 10 black Americans suffer from suicidal ...
Cached Medicine News:Health News:Wide Differences between NHS staff and ministers 2Health News:Fat or old - Swig red wine to live long says study 2
... The model 55S Rocking Shaker provides ... and blotted membranes. The very slow ... degree of tilt provide a gentle ... over gels and blotted membranes to ...
Plate Roller...
Conversion Kits For Modular Incubator Chamber...
Multi-Tier Shaker...
Medicine Products: